All lobbying filings

KING & SPALDING LLP

KING & SPALDING LLP filed a Q1 report for EGENESIS INC. on April 20, 2026, reporting $60,000 in lobbying income.

Lobbying for EGENESIS INC. · Gene editing platform for the development of transplantable organs.

All filings by KING & SPALDING LLP · Everything EGENESIS INC. has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Income

$60,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Educate lawmakers on xenotransplantation.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem